title: Bacteriological investigation of infected pressure ulcers in spinal cord-injured patients and impact on antibiotic therapy.
abstract: METHODS
  Retrospective.
  
  
  OBJECTIVE
  To improve the use of bacteriological results for treating spinal cord-injured patients with infected pressure ulcers.
  
  
  METHODS
  Microbiology and Orthopaedics Department, Ambroise Paré University Hospital, Boulogne-Billancourt, France.
  
  
  METHODS
  Tissue specimens, sampled at the end of the surgical intervention from unbridled and cleaned ulcers were analysed. Drainage liquids were cultured at day 1 (D1) and day 5 (D5) postsurgery. For part of the patients, a presurgery superficial sample was analysed and compared with the surgical and postsurgical samples.
  
  
  RESULTS
  In all, 168 surgical samples from 101 patients, 183 D1 and 104 D5 wound drainage liquids were included in this study. Out of the 168 surgical samples 17 (10%) had a negative culture, whereas 151 (90%) had a positive culture. For drainage liquids, the culture was negative in 48% and 56% of the samples at D1 and D5, respectively. The most frequently isolated species were enterobacteria, followed by staphylococci and streptococci.
  
  
  CONCLUSIONS
  Culturing deep tissue specimens sampled from the surgically cleaned and unbridled ulcers allows for the isolation of the bacterial species that are really involved in the ulcer infection. As the identification of these bacteria and their antibiotic susceptibility are available, when the culture results of the D1 postsurgical drainage liquid is also available, it is easier to choose targeted antibiotic treatment.
authors.affiliation: Service de Microbiologie-Hygiène, Hôpital Ambroise-Paré, Faculté de Médecine Paris Ile de France Ouest, France.
authors.forename: B
authors.initials: B
authors.lastname: Heym
authors.forename: F
authors.initials: F
authors.lastname: Rimareix
authors.forename: A
authors.initials: A
authors.lastname: Lortat-Jacob
authors.forename: M-H
authors.initials: MH
authors.lastname: Nicolas-Chanoine
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy; D015331:Cohort Studies; D003646:Debridement; D005260:Female; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D015601:Injury Severity Score; D008297:Male; D008826:Microbial Sensitivity Tests; D003668:Pressure Ulcer / Q000188:drug therapy* / Q000382:microbiology* / Q000601:surgery; D012189:Retrospective Studies; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D013119:Spinal Cord Injuries / Q000150:complications* / Q000175:diagnosis / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents